Objectives: There is growing recognition that a comprehensive economic assessment of a
new health‐care intervention at the time of launch requires both a cost‐effectiveness …

A budget impact analysis for a new pharmaceutical product provides estimates of the likely
impact of the new drug on a healthcare decision maker's short-and longer-term annual …

As healthcare budgets are continuously rising in Europe, governments implement a wide
variety of policies to control them. Reference pricing is a popular tool for governments to …

There are three known criteria that underlie drug reimbursement decisions: therapeutic
value, cost-effectiveness, and burden of disease. However, evidence from recent …

A budget impact analysis (BIA) is used to assess whether the adoption of a new health
technology is affordable, given the resource and budget constraints of the context …

Objective To assess the impact of reference pricing and extension of generic substitution on
the daily cost of antipsychotic drugs in Finland during the first year after its launch …

There are three known criteria that underlie drug reimbursement decisions: therapeutic
value, cost effectiveness and burden of disease. However, evidence from recent …

Objectives To analyze the medium-to long-term impact of generic substitution and the
reference price system on the daily cost of antipsychotics in Finland. The additional impact of …

Background: Attention-deficit hyperactivity disorder (ADHD) is the most common mental
health disorder in youths. Stimulants are the drugs of first choice in the treatment of ADHD. It …

Abstract Background South Africa faces a heavy burden of disease, which impacts resource
allocation. The needs of South Africa require efficient translation into pharmaceutical …